BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30476894)

  • 1. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.
    Terlević R; Perić Balja M; Tomas D; Skenderi F; Krušlin B; Vranic S; Demirović A
    Ann Diagn Pathol; 2019 Feb; 38():62-66. PubMed ID: 30476894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
    Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
    Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
    Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
    Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix.
    Kajiwara H; Hirabayashi K; Miyazawa M; Nakamura N; Hirasawa T; Muramatsu T; Mikami M; Yasuda M; Osamura RY
    Arch Gynecol Obstet; 2009 Apr; 279(4):521-5. PubMed ID: 18726606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.
    Charoenpitakchai M; Liu E; Zhao Z; Koyama T; Huh WJ; Berlin J; Hande K; Walker R; Shi C
    Virchows Arch; 2017 May; 470(5):545-552. PubMed ID: 28213807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of somatostatin receptor profile of neuroendocrine carcinomas of the breast.
    Kontogeorgos G; Thodou E; Choreftaki T
    Pathol Res Pract; 2020 Sep; 216(9):153066. PubMed ID: 32825939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity.
    Gardair C; Samimi M; Touzé A; Coursaget P; Lorette G; Caille A; Wierzbicka E; Croué A; Avenel-Audran M; Aubin F; Kerdraon R; Estève E; Beneton N; Guyétant S
    Neuroendocrinology; 2015; 101(3):223-35. PubMed ID: 25765179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
    Herac M; Niederle B; Raderer M; Krebs M; Kaserer K; Koperek O
    APMIS; 2016 Oct; 124(10):839-45. PubMed ID: 27539746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma.
    Tao L; Chen Y; Shi X; Yu G; Yin W; Huang Y
    Virchows Arch; 2020 Oct; 477(4):573-579. PubMed ID: 32328798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs.
    Kasajima A; Papotti M; Ito W; Brizzi MP; La Salvia A; Rapa I; Tachibana T; Yazdani S; Sasano H; Volante M
    Hum Pathol; 2018 Feb; 72():144-152. PubMed ID: 29180250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
    Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
    Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma.
    Tang X; Takekoshi S; Itoh J; Umemura S; Shoji S; Terachi T; Osamura RY
    Int J Oncol; 2010 Nov; 37(5):1077-83. PubMed ID: 20878055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
    Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
    Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
    Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
    Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the expression of somatostatin receptors by immunohistochemistry in neuroendocrine tumors of the small intestine.
    Pol J Pathol; 2020; 71(1):30-37. PubMed ID: 32429652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.
    Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Baum RP; Prasad V; Hommann M
    Int J Clin Exp Pathol; 2012; 5(3):187-94. PubMed ID: 22558472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and their clinical significance of SSTR2A, SSTR5 and EGFR in non-small cell lung cancer].
    Liu X; Tian H; Wang X; Ding J
    Zhongguo Fei Ai Za Zhi; 2007 Feb; 10(1):14-9. PubMed ID: 21110926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin and dopamine receptor profile of gastroenteropancreatic neuroendocrine tumors: an immunohistochemical study.
    Diakatou E; Kaltsas G; Tzivras M; Kanakis G; Papaliodi E; Kontogeorgos G
    Endocr Pathol; 2011 Mar; 22(1):24-30. PubMed ID: 21287294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.